A San Francisco startup has begun testing a brain implant in humans that aims to detect and one day treat cancer. Three people have received the device so far.
Coherence Neuro, a company with ties to Elon Musk’s Neuralink, launched human trials of its brain-computer interface. The implant is designed to detect cancer and could eventually use electrical stimulation to prevent tumors from growing.
The testing marks an early step in applying brain interfaces to medical conditions beyond paralysis or neurological disorders. Company researchers say the device targets tumors through direct monitoring and potential intervention.
Details on the patients or trial outcomes remain limited at this stage. The effort focuses on safety and feasibility in the initial phase.